Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05752760Not ApplicableCompleted
Pilot Study Lp299v Supplementation in Chronic Heart Failure
Heart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction+2 more
PrincipalinvestigatorStart date: 2023-02-20
NCT05296395Not ApplicableActive Not Recruiting
Vascular Aging and Lp299v Study in Healthy Adults
Vascular Aging
PrincipalinvestigatorStart date: 2023-02-01
NCT01952834Phase 4Completed
Effect of Probiotic Supplementation on Endothelial Function
Coronary Artery Disease
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John Baker, PhD

Medical College of Wisconsin

Related
2 trials

Shared therapeutic areas:

Coronary Artery Disease

Worked with same sponsors:

Medical College of Wisconsin
Collaborated on 1 trial
Similarity Score14%

Joo Myung Lee, MD, MPH, PhD

Samsung Medical Center

Related
17 trials

Shared therapeutic areas:

Coronary Artery DiseaseHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction
Similarity Score13%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Heart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction
Similarity Score13%

Shao-Liang Chen, MD

Nanjing First Hospital, Nanjing Medical University

Related
9 trials

Shared therapeutic areas:

Coronary Artery DiseaseHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction
Similarity Score13%

Muhammad iqbal Tariq, PhD*

Riphah International University

Related
16 trials

Shared therapeutic areas:

Heart FailureCoronary Artery Disease
Similarity Score9%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Heart Failure
Similarity Score4%

Jiyan Chen, M.D.

Guangdong Provincial People's Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score4%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score4%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Heart Failure
Similarity Score4%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05752760Not ApplicablePrincipalInvestigator

Pilot Study Lp299v Supplementation in Chronic Heart Failure

Heart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction+2 more
Completed
NCT05296395Not ApplicablePrincipalInvestigator

Vascular Aging and Lp299v Study in Healthy Adults

Vascular Aging
Active Not Recruiting
NCT01952834Phase 4PrincipalInvestigator

Effect of Probiotic Supplementation on Endothelial Function

Coronary Artery Disease
Completed

All 3 trials loaded